Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study
Author
Date
2025-02-21Permanent link
http://hdl.handle.net/11351/12977DOI
10.3389/fendo.2025.1529418
ISSN
1664-2392
WOS
001439188000001
PMID
40060376
Abstract
Background: The outcomes of transsphenoidal surgery (TSS) for pituitary adenoma (PA) depend on many factors, including the availability of an expert team and the volume of surgeries performed. Data on the outcomes of TSS for PA are scarce in our country. TESSPAIN evaluates TSS outcomes in Spanish centers to assess the influence of surgical volume and specialized neurosurgical teams on success and complication rates.
Methods: A retrospective, nationwide, study of Spanish centers performing TSS between January 2018 and December 2022. Centers were classified as high volume (HV) [n=11, defined as centers with recognized expertise in Spain or those performing more than 25 TSS/year] or non-HV. Data collection included surgical success rates, complications, and pituitary adenoma resectability (R-PA). Additional analyses evaluated the impact of dedicated neurosurgical teams (DNT) within HV centers.
Results: A total of 2815 TSS from 29 Spanish centers were included (1421 NSPA, 436 GH-secreting, 323 Cushing’s disease, 127 PRL-secreting and 25 TSH-secreting PA). The overall success rate was 50.5%, 76.8% for R-PA. HV centers had a higher overall success rate (53.1 vs. 47.7%; p=0.03). Better TSS outcomes for NSPA accounted for this difference. The overall TSS complication rate was 22.1%, which was higher for NSPA than for SPA (25.0 vs. 17.7%). The overall complication rate of TSS for PA was significantly higher in non-HV centers than in HV centers (24 vs 20.4.0; p <0.01). Centers with a DNT showed a trend to higher success rate in R-PA, while having a lower overall incidence of complications in TSS for PA than HV centers without a DNT (18.5 vs. 23.0; p=0.058), mainly reducing the rate of permanent ADH deficiency in all TSS for PA (2.7 vs. 8.4%; p<0.001).
Conclusion: Higher surgical volume and DNT are associated with improved TSS outcomes for PA in Spain. Our results support the recommendation of concentration of pituitary surgery in a reduced number of centers of expertise in our country in order to improve the success rate and reduce complications, mainly postoperative ADH deficiency.
Keywords
Pituitary adenoma; Surgical specialization; Transsphenoidal surgeryBibliographic citation
Paja M, Soto A, Hanzu FA, Guerrero-Pérez F, Cámara R, Moure D, et al. Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study. Front Endocrinol (Lausanne). 2025 Feb 21;16:1529418.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
The following license files are associated with this item:





